Research & Development - Driving Innovation at Farmson

Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-art R&D center, Farmson develops innovative, non-infringing processes for APIs and DC granules while ensuring global regulatory readiness. Supported by advanced synthesis, analytical, and formulation facilities, Farmson’s R&D drives cost-effective, scalable, and sustainable solutions. Through continuous innovation and collaborative development, Farmson strengthens its API portfolio and delivers high-quality medicines to global markets.

For More Information Visit: https://www.farmson.com/blogs/research-development-driving-innovation-at-farmson/

Global Leadership in Paracetamol API Production

Farmson Basic Drugs is the world’s largest integrated manufacturer of Paracetamol API, with over five decades of leadership and a capacity of 53,000 MTPA—equivalent to 96.1 billion tablets annually. Supplying nearly 40% of India’s demand and exporting to 65+ countries, Farmson combines backward integration, multiple formulation grades, and global regulatory approvals. Its commitment to quality, innovation, and reliability has made Farmson the trusted backbone of paracetamol-based medicines worldwide.

For More Information Visit: https://www.farmson.com/blogs/global-leadership-in-paracetamol-api-production/

Farmson’s Commitment to Sustainability in Pharma Manufacturing

Farmson Basic Drugs embeds sustainability at the heart of pharmaceutical manufacturing through eco-friendly, solvent-free processes, renewable energy adoption, and responsible resource management. From solar power and cogeneration to water recycling and material recovery systems, Farmson actively reduces its environmental footprint. Backed by ethical sourcing, community initiatives, and efficient operations, the company proves that high-quality pharma manufacturing can go hand in hand with environmental stewardship and long-term sustainability.

For More Information Visit: https://www.farmson.com/blogs/farmsons-commitment-to-sustainability-in-pharma-manufacturing/

Expanding the API Portfolio - Farmson’s New API Offerings

Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology, and nutritional therapies. New offerings such as Theophylline, Mirabegron, Folic Acid, Levosalbutamol, Theobromine, and Rivaroxaban reflect Farmson’s commitment to quality, compliance, and innovation. Backed by strong R&D, scalable facilities, and global regulatory standards, this expansion enables customers to source multiple critical APIs from one trusted partner.

For More Information Visit: https://www.farmson.com/blogs/expanding-the-api-portfolio-farmsons-new-api-offerings/

Excellence in Paracetamol DC Granules Manufacturing

Farmson Basic Drugs sets industry benchmarks in Paracetamol DC granules through world-class, EU-GMP–certified manufacturing and advanced GLATT granulation technology. With a capacity of 3,600 MTPA, flexible batch sizes, multiple grades, and full pharmacopeial compliance, Farmson delivers tablet-ready granules with excellent flow and compressibility. Supported by in-house FR&D, customization options, and integrated API-to-DC production, Farmson simplifies tablet manufacturing while ensuring consistent quality and global reliability.

For More Information Visit: https://www.farmson.com/blogs/excellence-in-paracetamol-dc-granules-manufacturing/

Caffeine API Manufacturing – Farmson’s State-of-the-Art Facility

Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic caffeine facility. Built on decades of chemical expertise, the plant follows a seven-stage process with strict impurity control and GMP compliance. Producing high-purity, stable Form-II caffeine that meets global pharmacopeial standards, Farmson ensures scalable supply, regulatory readiness, and consistent quality for pharmaceutical, food, and beverage applications worldwide.

For More Information Visit: https://www.farmson.com/blogs/caffeine-api-manufacturing-farmsons-state-of-the-art-facility/

Farmson - Leading Caffeine API Manufacturer in India

Farmson is a reputed caffeine manufacturer in India, offering pharmaceutical-grade caffeine API for global pharmaceutical and nutraceutical applications. With GMP-certified manufacturing, robust quality assurance, and decades of industry experience, Farmson ensures reliable supply, consistency, and compliance for customers worldwide.

For More Information Visit: https://www.farmson.com/products/caffeine